Frontier Wealth Management’s Checkpoint Therapeutics CKPT Stock Holding History

Frontier Wealth Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-35,398	Closed	-$1.04M	–	427
2021 Q2	$1.04M	Hold	35,398	–	–	0.07%	172
2021 Q1	$1.11M	Hold	35,398	–	–	0.09%	153
2020 Q4	$938K	Hold	35,398	–	–	0.08%	165
2020 Q3	$949K	Buy	+35,398	New	+$850K	0.09%	156
2019 Q2	–	Sell	-21,100	Closed	-$603K	–	320
2019 Q1	$603K	Buy	21,100 +4,100	+24%	+$131K	0.08%	199
2018 Q4	$309K	Hold	17,000	–	–	0.05%	257
2018 Q3	$608K	Buy	17,000 +2,000	+13%	+$69.8K	0.06%	199
2018 Q2	$447K	Buy	15,000 +5,000	+50%	+$173K	0.06%	227
2018 Q1	$439K	Buy	+10,000	New	+$434K	0.06%	241

Other funds holding CKPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSMC

Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Frontier Wealth Management's CKPT Position: Q3 2021 in Review

Frontier Wealth Management sold out of Checkpoint Therapeutics (CKPT) in Q3 2021, closing a stake of 35,398 shares — an estimated $1.04M sold.

Frontier Wealth Management first reported a position in CKPT in Q1 2018 and held it in 9 quarters. The position peaked at $1.11M in Q1 2021. 67 funds tracked by Wall St. Rank hold CKPT as of Q3 2021.

Frontier Wealth Management reported no remaining Checkpoint Therapeutics position as of Q3 2021 after selling out during the quarter.
Frontier Wealth Management sold 35,398 Checkpoint Therapeutics shares in Q3 2021, an estimated $1.04M.
Frontier Wealth Management first reported a position in Checkpoint Therapeutics in Q1 2018 and held it in 9 quarters.
Frontier Wealth Management's Checkpoint Therapeutics position peaked at $1.11M in Q1 2021.
67 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2021.

Based on Frontier Wealth Management's 13F filing for Q3 2021, filed 12 Nov 2021.